Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof

Details for Australian Patent Application No. 2004312332 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors August, Paul; Kuntzweiler, Theresa; Baskaran, Namadev; Parkar, Ashfaq; Ardati, Mohamad Ali

Agent Watermark

Pub. Number AU-B-2004312332

PCT Pub. Number WO2005/066209

Priority 10/747,994 30.12.03 US

Filing date 7 December 2004

Wipo publication date 21 July 2005

Acceptance publication date 20 May 2010

International Classifications

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066209 Priority application(s): WO2005/066209

20 May 2010 Application Accepted

  Published as AU-B-2004312332

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312335-Lubricating base oil with high monocycloparaffins and low multicycloparaffins

2004312331-Blow molding resins with improved ESCR